Skip to main content
. Author manuscript; available in PMC: 2010 May 4.
Published in final edited form as: Epidemics. 2009 Mar 1;1(1):47–57. doi: 10.1016/j.epidem.2008.10.002

Figure 3.

Figure 3

Incidence of chronic HCV infection (ppy) after the introduction of a hypothetical HCV vaccine, by targeting strategy: A. no targeting, B. risk targeting, and C. sero-targeting, efficacy, and vaccination rate over time. Figures show the mean of 100 realizations. Standard deviations 30 years after vaccine introduction range from 0.006 (for lower incidence) to 0.019 (for higher incidence).